Back to MORGAN STANLEY MORGAN STANLEY

ETONETON
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in ETON PHARMACEUTICALS INC

Yes. Morgan Stanley holds 767,972 shares of ETON (Eton Pharmaceuticals), worth $27.8M, as of its Q2 2026 13F filing. It increased the position by 290,015 shares (+60.7%) from Q1 2026. Morgan Stanley has held ETON in every 13F on record since Q2 2024, 9 quarterly filings.

Current Value

$27.8M

Current Shares

767,972

Total Value Change

+$27.8M

Total Shares Change

+767,780

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
767,972
+60.7%
$27.8M0.0%$36.20
41
2026-Q1
Decreased
477,957
-3.2%
$11.8M0.0%$24.68
0
2025-Q4
Decreased
493,914
-15.7%
$8.4M0.0%$16.91
0
2025-Q3
Increased
586,046
+15.0%
$12.7M0.0%$21.73
32
2025-Q2
Increased
509,568
+245.9%
$7.3M0.0%$14.25
44
2025-Q1
Increased
147,332
+1016.7%
$1.9M0.0%$12.98
42
2024-Q4
Increased
13,193
+2695.1%
$175,7310.0%$13.32
25
2024-Q3
Increased
472
+145.8%
$2,8320.0%$6.00
14
2024-Q2
First report
192
-
$6320.0%$3.29
0

Other major holders of ETON: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used